Pesquisar
IRIDEX Corp
IRIXAdicionar à lista de desejos
0.820USD
-0.001-0.13%
Fechamento 07-31 16:00（ET）Cotações atrasadas em 15 min
13.98MValor de mercado
PerdaP/L TTM
Mais detalhes de IRIDEX Corp Empresa
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Informações de IRIDEX Corp
Código da empresaIRIX
Nome da EmpresaIRIDEX Corp
Data de listagemFeb 16, 1996
CEOMercer (Patrick)
Número de funcionários93
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 16
Endereço1212 Terra Bella Ave
CidadeMOUNTAIN VIEW
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94043
Telefone16509404700
Sitehttps://www.iridex.com/
Código da empresaIRIX
Data de listagemFeb 16, 1996
CEOMercer (Patrick)
Executivos da empresa IRIDEX Corp
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. William M. (Will) Moore, Jr.
Mr. William M. (Will) Moore, Jr.
Independent Director
Independent Director
402.00K
--
Mr. Patrick Mercer
Mr. Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
262.07K
+38.16%
Mr. Romeo R. Dizon
Mr. Romeo R. Dizon
Chief Financial Officer
Chief Financial Officer
140.78K
+21.31%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
92.64K
--
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Yu Hao (Nick) Chen
Mr. Yu Hao (Nick) Chen
Independent Director
Independent Director
--
--
Mr. Bassem Bouhabib
Mr. Bassem Bouhabib
Vice President - International Sales
Vice President - International Sales
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. William M. (Will) Moore, Jr.
Mr. William M. (Will) Moore, Jr.
Independent Director
Independent Director
402.00K
--
Mr. Patrick Mercer
Mr. Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
262.07K
+38.16%
Mr. Romeo R. Dizon
Mr. Romeo R. Dizon
Chief Financial Officer
Chief Financial Officer
140.78K
+21.31%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
92.64K
--
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Yu Hao (Nick) Chen
Mr. Yu Hao (Nick) Chen
Independent Director
Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de IRIDEX Corp?
Os cinco principais acionistas de IRIDEX Corp são: Mr. William M. (Will) Moore, Jr.
Quantas instituições possuem ações da IRIDEX Corp (IRIX)?
Em 2026Q1, 52 instituições possuíam ações da IRIDEX Corp, com valor de mercado aproximado de 3.69M, representando 21.29% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 278304.00.
Qual é a maior fonte de receita da IRIDEX Corp?
Em 2026Q1, o segmento de negócios Retina gerou a maior receita para IRIDEX Corp, totalizando 6.70M e representando 53.65% da receita total.